Evidence map›Paper›PMID 41214301›Full record

GuidelineInternational journal of clinical oncology2026

Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer.

Kohji Tanakaya, Tatsuro Yamaguchi, Keiji Hirata, Masayoshi Yamada, Kensuke Kumamoto, Yasuki Akiyama, Kei Ishimaru, Koichi Okamoto, Yuko Kawasaki, Keigo Komine and 39 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in International journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors.

Kohji TanakayaDepartment of Surgery, National Hospital Organization Iwakuni Clinical Center, 1-1-1 Atago-Machi, Iwakuni, 740-8510, Japan. tanakaya.kouji.tb@mail.hosp.go.jp.ORCID http://orcid.org/0000-0001-8901-6911
Tatsuro YamaguchiDepartment of Clinical Genetics, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Keiji HirataDepartment of Surgery 1, University of Occupational and Environmental Health, Kitakyushu, Japan.
Masayoshi YamadaEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Kensuke KumamotoDepartment of Genome Medical Science and Medical Genetics, Faculty of Medicine, Kagawa University, Kita-Gun, Japan.
Yasuki AkiyamaDepartment of Surgery 1, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kei IshimaruDivision of Gastrointestinal Surgery and Surgical Oncology, Graduate School of Medicine, Ehime University, Toon, Japan.
Koichi OkamotoDepartment of Gastroenterology and Oncology, Tokushima University Graduate School of Medical Science, Tokushima, Japan.
Yuko KawasakiCollege of Nursing, University of Hyogo, Akashi, Japan.
Keigo KomineDepartment of Medical Oncology, Tohoku University Hospital, Sendai, Japan.
Akira SakamotoDepartment of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Kunitoshi ShigeyasuDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Yoshiko ShibataHimawari-No-Kai (Sunflower Association), a Patient Advocacy Group for Individuals and Families Affected By Lynch Syndrome, Iwakuni, Japan.
Yusaku ShimamotoDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Hideki ShimodairaDivision of Medical Oncology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Shigeki SekineDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Akinari TakaoDepartment of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Misato TakaoDepartment of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Yasuyuki TakamizawaDepartment of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
Yoji TakeuchiDepartment of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Gunma, Japan.
Noriko TanabeDepartment of Clinical Genetics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Fumitaka TaniguchiDepartment of Surgery, Hiroshima City Hospital Organization Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Akiko ChinoDepartment of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Hourin ChoEndoscopy Center, Tokyo Medical University Hospital, Tokyo, Japan.
Satoru DoiHarmony Line (Association for Patients and Families With Familial Adenomatous Polyposis), Osaka, Japan.
Takeshi NakajimaDivision of Hereditary Tumors, Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Sakiko NakamoriDepartment of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Yoshiko NakayamaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Toshiya NagasakiDepartment of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
Hisashi HasumiDepartment of Urology, Yokohama City University, Yokohama, Japan.
Kouji BannoCenter of Maternal -Fetal/Neonatal Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Takao HinoiDepartment of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan.
Kenji FujiyoshiDepartment of Surgery, Kurume University School of Medicine, Kurume, Japan.
Takahiro HorimatsuInstitute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.
Kenta MasudaDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Masashi MiguchiDepartment of Gastroenterological Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Yusuke MizuuchiDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yasuyuki MiyakuraDepartment of Colon and Pelvic Surgery, Cancer Prevention and Genetic Counseling, Tochigi Cancer Center, Utsunomiya, Japan.
Michihiro MutohDepartment of Molecular-Targeting Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takahiro YoshiokaDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi, Japan.
Shinji TanakaJA Onomichi General Hospital, Onomichi, Japan.
Kazuhiro SakamotoKoshigaya Municipal Hospital, Koshigaya, Japan.
Kentaro SakamakiFaculty of Health Data Science, Juntendo University, Tokyo, Japan.
Michio ItabashiSaiseikai Kazo Hospital, Kazo, Japan.
Hideyuki IshidaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Naohiro TomitaDivision of Cancer Treatment , Toyonaka Municipal Hospital, Toyonaka, Japan.
Kenichi SugiharaInstitute of Science Tokyo , Tokyo, Japan.
Yoichi AjiokaDivision of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Japanese Society for Cancer of the Colon, Rectum

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 5% of all colorectal cancers have a strong genetic component and are classified as hereditary colorectal cancer (HCRC). Some of the unique features commonly seen in HCRC cases include early age of onset, synchronous/metachronous cancer occurrence, and multiple cancers in other organs. These characteristics require different management approaches, including diagnosis, treatment or surveillance, from those used in the management of sporadic colorectal cancer. Accurate diagnosis of HCRC is essential because it enables targeted surveillance and risk reduction strategies that improve patient outcomes. Recent genetic advances revealed several causative genes for polyposis and non-polyposis syndromes. The Japanese Society for Cancer of the Colon and Rectum (JSCCR) first published guidelines for the management of HCRC in 2012, with subsequent revisions every 4 years. The 2024 update to the JSCCR guidelines for HCRC was developed by meticulously reviewing evidence from systematic reviews and the consensus of the JSCCR HCRC Guidelines Committee, which includes representatives from patient advocacy groups for FAP and Lynch syndrome. These guidelines provide an up-to-date summary of HCRC, along with clinical recommendations for managing FAP and Lynch syndrome.

Indexed as

Adenomatous Polyposis ColiColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisHumansJapanFamilial adenomatous polyposisGuidelinesHereditary colorectal cancerLynch syndrome

Identifiers

PMID41214301
PMCPMC12770061

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.